Skip to content
TriangleGet started
← Back to this collection

PUBLICATIONS · 33301740

Short-course radiotherapy followed by chemotherapy before total mesorectal excision (TME) versus preoperative chemoradiotherapy, TME, and optional adjuvant chemotherapy in locally advanced rectal cancer (RAPIDO): a randomised, open-label, phase 3 trial.

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
Lancet Oncol
Publication date
2021 Jan
First author
Bahadoer RR

This record carries publication-notice metadata. Review the notices below before relying on it.

Publication notices

absence is not clearance
true
has correction metadata
true
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    Lancet Oncol. 2021 Jan;22(1):2-3. doi: 10.1016/S1470-2045(20)30643-4.
    note
    Source null
    related pmid
    33301739
    relationship
    Comment in
  2. citation
    Lancet Oncol. 2021 Feb;22(2):e42. doi: 10.1016/S1470-2045(20)30781-6.
    note
    Source null
    related pmid
    33539749
    relationship
    Erratum in
  3. citation
    Lancet Oncol. 2021 Mar;22(3):e85. doi: 10.1016/S1470-2045(21)00013-9.
    note
    Source null
    related pmid
    33662293
    relationship
    Comment in
  4. citation
    Lancet Oncol. 2021 Mar;22(3):e86. doi: 10.1016/S1470-2045(21)00011-5.
    note
    Source null
    related pmid
    33662294
    relationship
    Comment in
  5. citation
    Lancet Oncol. 2021 Mar;22(3):e87-e88. doi: 10.1016/S1470-2045(21)00061-9.
    note
    Source null
    related pmid
    33662295
    relationship
    Comment in
  6. citation
    Lancet Oncol. 2021 Mar;22(3):e89. doi: 10.1016/S1470-2045(21)00072-3.
    note
    Source null
    related pmid
    33662296
    relationship
    Comment in
  7. citation
    Lancet Oncol. 2021 Mar;22(3):e90-e91. doi: 10.1016/S1470-2045(21)00087-5.
    note
    Source null
    related pmid
    33662297
    relationship
    Comment in
  8. citation
    Strahlenther Onkol. 2021 Jun;197(6):567-569. doi: 10.1007/s00066-021-01763-8.
    note
    Source null
    related pmid
    33765184
    relationship
    Comment in

Authors and identifiers

  1. name
    Bahadoer RR
    type
    Author
  2. name
    Dijkstra EA
    type
    Author
  3. name
    van Etten B
    type
    Author
  4. name
    Marijnen CAM
    type
    Author
  5. name
    Putter H
    type
    Author
  6. name
    Kranenbarg EM
    type
    Author
  7. name
    Roodvoets AGH
    type
    Author
  8. name
    Nagtegaal ID
    type
    Author
  9. name
    Beets-Tan RGH
    type
    Author
  10. name
    Blomqvist LK
    type
    Author
  11. name
    Fokstuen T
    type
    Author
  12. name
    Ten Tije AJ
    type
    Author
Complete bibliographic record and source provenance
authors
  1. name
    Bahadoer RR
    type
    Author
  2. name
    Dijkstra EA
    type
    Author
  3. name
    van Etten B
    type
    Author
  4. name
    Marijnen CAM
    type
    Author
  5. name
    Putter H
    type
    Author
  6. name
    Kranenbarg EM
    type
    Author
  7. name
    Roodvoets AGH
    type
    Author
  8. name
    Nagtegaal ID
    type
    Author
  9. name
    Beets-Tan RGH
    type
    Author
  10. name
    Blomqvist LK
    type
    Author
  11. name
    Fokstuen T
    type
    Author
  12. name
    Ten Tije AJ
    type
    Author
bibliography ids
  1. nci-bib-08d469f62eefbb30f817e0bb
book metadata
content sha256
ad7af8ec186426b7ebf0459799f592e641e0bc3e557aa20d5080c2ec9935a152
document type
citation
dois
  1. 10.1016/S1470-2045(20)30555-6
electronic publication date
display
2020 Dec 7
precision
day
year
2020
evidence scope
bibliographic_metadata_only
id
pubmed:33301740
immutable id
pubmed:33301740@ad7af8ec186426b7ebf0459799f592e641e0bc3e557aa20d5080c2ec9935a152
journal
abbreviation
Lancet Oncol
issn electronic
1474-5488
issn print
1470-2045
issue
1
name
The Lancet. Oncology
nlm unique id
100957246
pages
29-42
volume
22
languages
  1. eng
notices
absence is not clearance
true
has correction metadata
true
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    Lancet Oncol. 2021 Jan;22(1):2-3. doi: 10.1016/S1470-2045(20)30643-4.
    note
    Source null
    related pmid
    33301739
    relationship
    Comment in
  2. citation
    Lancet Oncol. 2021 Feb;22(2):e42. doi: 10.1016/S1470-2045(20)30781-6.
    note
    Source null
    related pmid
    33539749
    relationship
    Erratum in
  3. citation
    Lancet Oncol. 2021 Mar;22(3):e85. doi: 10.1016/S1470-2045(21)00013-9.
    note
    Source null
    related pmid
    33662293
    relationship
    Comment in
  4. citation
    Lancet Oncol. 2021 Mar;22(3):e86. doi: 10.1016/S1470-2045(21)00011-5.
    note
    Source null
    related pmid
    33662294
    relationship
    Comment in
  5. citation
    Lancet Oncol. 2021 Mar;22(3):e87-e88. doi: 10.1016/S1470-2045(21)00061-9.
    note
    Source null
    related pmid
    33662295
    relationship
    Comment in
  6. citation
    Lancet Oncol. 2021 Mar;22(3):e89. doi: 10.1016/S1470-2045(21)00072-3.
    note
    Source null
    related pmid
    33662296
    relationship
    Comment in
  7. citation
    Lancet Oncol. 2021 Mar;22(3):e90-e91. doi: 10.1016/S1470-2045(21)00087-5.
    note
    Source null
    related pmid
    33662297
    relationship
    Comment in
  8. citation
    Strahlenther Onkol. 2021 Jun;197(6):567-569. doi: 10.1007/s00066-021-01763-8.
    note
    Source null
    related pmid
    33765184
    relationship
    Comment in
outcomes validated
false
pmid
33301740
provenance
batch id
9bca82d1bba2b27adc79
provider
NCBI PubMed ESummary
record sha256
8c36bf2b9a7656356c932b097d86a0edf5266d4f77932d01c331098eb6c4a011
response sha256
c8a4853c65a45038af15f5ade3970763bfa121cf5c68bafcc52c3a06860d0211
retrieved at
2026-09-09T23:47:56.131551+00:00
publication date
display
2021 Jan
precision
month
year
2021
publication types
  1. Clinical Trial, Phase III
  2. Comparative Study
  3. Journal Article
  4. Multicenter Study
  5. Randomized Controlled Trial
  6. Research Support, Non-U.S. Gov't
record status
PubMed - indexed for MEDLINE
schema version
1.0
source url
https://pubmed.ncbi.nlm.nih.gov/33301740/
title
Short-course radiotherapy followed by chemotherapy before total mesorectal excision (TME) versus preoperative chemoradiotherapy, TME, and optional adjuvant chemotherapy in locally advanced rectal cancer (RAPIDO): a randomised, open-label, phase 3 trial.

Preserved source evidence · Independent clinical review pending · Not medical advice